Loyd Hudson has a strong background in pharmaceutical sciences, particularly in the areas of absorption, distribution, metabolism, and excretion (ADME), with extensive experience at Eli Lilly and Company from March 2021 to March 2022, including roles such as Associate Director of ADME Scientific Oversight and Sr. Principal Scientist-ADME. Prior to this, Loyd held various positions within the ADME field and worked as an Associate Director in Clinical Biomarkers and Diagnostic Development. Loyd's earlier experience includes medical technology roles at Alverno Clinical Laboratories and Alverno Laboratories. Loyd earned a Bachelor of Science in Microbiology from Ball State University from 2002 to 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices